Fairfield, Bush & Co’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,103
Closed -$121K 120
2023
Q4
$121K Buy
+1,103
New +$110K 0.07% 137
2023
Q3
Sell
-1,103
Closed -$120K 115
2023
Q2
$120K Buy
+1,103
New +$118K 0.03% 172
2022
Q3
Sell
-1,103
Closed -$120K 121
2022
Q2
$120K Buy
+1,103
New +$125K 0.07% 138
2018
Q2
Sell
-1,540
Closed -$92K 159
2018
Q1
$92K Buy
+1,540
New +$92.8K 0.03% 162
2013
Q4
Sell
-202
Closed -$6K 126
2013
Q3
$6K Hold
202
﹤0.01% 259
2013
Q2
$7K Buy
+202
New +$7.41K ﹤0.01% 238

Other funds holding ABT

Fairfield, Bush & Co's ABT Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Abbott (ABT) in Q1 2024, closing a stake of 1,103 shares — an estimated $121K sold.

Fairfield, Bush & Co first reported a position in ABT in Q2 2013 and held it in 6 quarters. The position peaked at $121K in Q4 2023. 2,904 funds tracked by Wall St. Rank hold ABT as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining Abbott position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 1,103 Abbott shares in Q1 2024, an estimated $121K.
  • Fairfield, Bush & Co first reported a position in Abbott in Q2 2013 and held it in 6 quarters.
  • Fairfield, Bush & Co's Abbott position peaked at $121K in Q4 2023.
  • 2,904 funds tracked by Wall St. Rank held Abbott as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.